ESMO 2014

Haematologic Malignancies

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...cancer-and-colorectal-cancer-in-recent-years

Body Abstract:Metastatic germ cell tumors represent a model of a curable malignant disease due to a unique chemosensitivity to cisplatin-based combination therapy resulting in long term survival rates of about 80%.

Date: 26 Sep 2014
Presenter: Carsten Bokemeyer
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Colon Cancer, Germ Cell Tumours, Rectal Cancer

http://oncologypro.esmo.org/Meeting-Resourc.../From-molecular-biology-to-Lazarus-responses

Body Abstract:Among the most dramatic incidents in oncology are the Lazarus responses, where moribund patients recover rapidly from the brink of death and return to their normal life.

Date: 26 Sep 2014
Presenter: Heikki Joensuu
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/A-lifetime-in-Paradise

Body Abstract:Although the global burden of cancer is not known with precision, it is certain that it has doubled over the last 25 years and is set to double again before 2030.

Date: 26 Sep 2014
Presenter: Peter Boyle
Resources: Abstract
Topic: Cancer Aetiology, Epidemiology, Prevention

http://oncologypro.esmo.org/Meeting-Resourc...-marker-based-clinical-decision-making-today

MethodsResultsConclusions

Date: 26 Sep 2014
Presenter: Michael Weller
Resources: Abstract
Topics: Central Nervous System Malignancies, Pathology/Molecular Biology, Personalised Medicine

http://oncologypro.esmo.org/Meeting-Resourc...ulating-biomarkers-What-does-this-mean-today

Date: 26 Sep 2014
Presenter: Klaus Pantel
Resources: Presentation, Webcast
Topics: Career Development, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ient-derived-models-therapeutic-implications

Date: 26 Sep 2014
Presenter: Joan Seoane
Resources: Presentation, Webcast
Topics: Career Development, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...rgeting-the-androgen-axis-in-prostate-cancer

Date: 26 Sep 2014
Presenter: Gerhardt Attard
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-discussion-When-to-start-treatment-in-mCRPC

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-drive-the-appropriate-sequencing-of-therapy

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-Satellite-Sessions/Welcome-and-introduction

Date: 26 Sep 2014
Presenter: Joan Carles
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer